MX2021001888A - Composiciones que comprenden cepas bacterianas. - Google Patents

Composiciones que comprenden cepas bacterianas.

Info

Publication number
MX2021001888A
MX2021001888A MX2021001888A MX2021001888A MX2021001888A MX 2021001888 A MX2021001888 A MX 2021001888A MX 2021001888 A MX2021001888 A MX 2021001888A MX 2021001888 A MX2021001888 A MX 2021001888A MX 2021001888 A MX2021001888 A MX 2021001888A
Authority
MX
Mexico
Prior art keywords
compositions
bacterial strains
stimulating
subject
composition
Prior art date
Application number
MX2021001888A
Other languages
English (en)
Spanish (es)
Inventor
Amy Beth HOLT
Imke Elisabeth MULDER
Suaad Ahmed
Emma Raftis
Emma Elizabeth Clare Hennessy
Delphine Louise Claudette Laute-Caly
Philip Cowie
Marsilio Adriani
Maria Christofi
Anna Ettorre
Original Assignee
4D Pharma Res Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1817648.7A external-priority patent/GB201817648D0/en
Priority claimed from GBGB1900335.9A external-priority patent/GB201900335D0/en
Priority claimed from GBGB1901203.8A external-priority patent/GB201901203D0/en
Application filed by 4D Pharma Res Limited filed Critical 4D Pharma Res Limited
Publication of MX2021001888A publication Critical patent/MX2021001888A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MX2021001888A 2018-08-17 2019-08-19 Composiciones que comprenden cepas bacterianas. MX2021001888A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP18189521 2018-08-17
GBGB1817648.7A GB201817648D0 (en) 2018-10-29 2018-10-29 Compositions comprising bacterial strains
GBGB1900335.9A GB201900335D0 (en) 2019-01-10 2019-01-10 Compositions comprising bacterial strains
GBGB1901203.8A GB201901203D0 (en) 2019-01-29 2019-01-29 Compositions comprising bacterial strains
PCT/EP2019/072181 WO2020035623A1 (en) 2018-08-17 2019-08-19 Compositions comprising bacterial strains

Publications (1)

Publication Number Publication Date
MX2021001888A true MX2021001888A (es) 2021-07-16

Family

ID=67874412

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021001888A MX2021001888A (es) 2018-08-17 2019-08-19 Composiciones que comprenden cepas bacterianas.

Country Status (14)

Country Link
US (1) US20210330786A1 (https=)
EP (1) EP3836945A1 (https=)
JP (1) JP2021534089A (https=)
KR (1) KR20210046007A (https=)
CN (1) CN113423413A (https=)
AU (1) AU2019322090A1 (https=)
BR (1) BR112021002917A2 (https=)
CA (1) CA3108235A1 (https=)
IL (1) IL280895A (https=)
MA (1) MA53228A (https=)
MX (1) MX2021001888A (https=)
SG (1) SG11202101580TA (https=)
TW (1) TW202023590A (https=)
WO (1) WO2020035623A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112195123B (zh) * 2020-10-12 2022-04-29 中科美大(福建)生物科技有限公司 一种植物乳杆菌及其制剂和应用
CN112522248B (zh) * 2020-11-10 2023-10-03 暨南大学 一种包裹型阴沟肠杆菌y16固体菌剂的制备方法及其应用
CN119144528B (zh) * 2024-11-20 2025-06-06 青岛诺和诺康生物科技有限公司 两歧双歧杆菌及其改善哮喘及组胺不耐受的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127916D0 (en) 2001-11-21 2002-01-16 Rowett Res Inst Method
CN101595133B (zh) 2006-10-27 2012-11-14 比利时胶囊公司 羟丙基甲基纤维素硬胶囊及制备方法
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
KR101156340B1 (ko) 2009-06-17 2012-06-13 고려대학교 산학협력단 비피도박테리움 브레베 ｌｍｃ５２０ 균주를 이용한 공액리놀렌산의 생산방법
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
AU2015244700B2 (en) * 2014-04-10 2020-08-27 Riken Compositions and methods for induction of Th17 cells
MA41020A (fr) * 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
NZ737752A (en) * 2015-06-15 2022-02-25 4D Pharma Res Ltd Compositions comprising bacterial strains
KR102844378B1 (ko) 2016-05-31 2025-08-07 모리나가 뉴교 가부시키가이샤 뇌기능 개선제

Also Published As

Publication number Publication date
CA3108235A1 (en) 2020-02-20
MA53228A (fr) 2021-11-24
KR20210046007A (ko) 2021-04-27
WO2020035623A1 (en) 2020-02-20
IL280895A (en) 2021-04-29
SG11202101580TA (en) 2021-03-30
TW202023590A (zh) 2020-07-01
CN113423413A (zh) 2021-09-21
BR112021002917A2 (pt) 2021-05-11
JP2021534089A (ja) 2021-12-09
EP3836945A1 (en) 2021-06-23
AU2019322090A1 (en) 2021-04-15
US20210330786A1 (en) 2021-10-28

Similar Documents

Publication Publication Date Title
MX2020012061A (es) Composiciones que comprenden cepas bacterianas.
SA517390513B1 (ar) تركيبات تشتمل على سلالات بكتيرية
IL283751A (en) Compositions comprising bacterial strains
IL277422A (en) compounds containing bacterial strains
IL279963A (en) compounds containing bacterial strains
MX2021001888A (es) Composiciones que comprenden cepas bacterianas.
IL281951A (en) compounds containing bacterial strains
IL279339A (en) compounds containing bacterial strains
IL279724B (en) compounds containing bacterial strains
EA202190554A1 (ru) Композиции, содержащие бактериальные штаммы
EA202092549A1 (ru) Композиции, содержащие бактериальные штаммы
SG11202104258TA (en) Compositions comprising bacterial strains
PT3723777T (pt) Composições que compreendem estirpes bacterianas
PT3743086T (pt) Composições compreendendo estirpes bacterianas
GB201820745D0 (en) Compositions comprising bacterial strains
GB201820744D0 (en) Compositions comprising bacterial strains
GB201820261D0 (en) Compositions comprising bacterial strains
GB201820230D0 (en) Compositions comprising bacterial strains
GB201820264D0 (en) Compositions comprising bacterial strains
GB201817648D0 (en) Compositions comprising bacterial strains
GB201817642D0 (en) Compositions comprising bacterial strains
GB201817641D0 (en) Compositions comprising bacterial strains
GB201814836D0 (en) Compositions comprising bacterial strains
GB201813460D0 (en) Compositions comprising bacterial strains
GB201813423D0 (en) Compositions comprising bacterial strains